Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis.
Tran T, Šterclová M, Mogulkoc N, Lewandowska K, Müller V, Hájková M, Kramer MR, Jovanović D, Tekavec-Trkanjec J, Studnicka M, Stoeva N, Hejduk K, Dušek L, Suissa S, Vašáková M; EMPIRE registry. Tran T, et al. Among authors: tekavec trkanjec j. Respir Res. 2020 Jan 8;21(1):11. doi: 10.1186/s12931-019-1271-z. Respir Res. 2020. PMID: 31915023 Free PMC article.
Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE.
Kolonics-Farkas AM, Šterclová M, Mogulkoc N, Kus J, Hájková M, Müller V, Jovanovic D, Tekavec-Trkanjec J, Littnerová S, Hejduk K, Vašáková M. Kolonics-Farkas AM, et al. Among authors: tekavec trkanjec j. Drug Saf. 2020 Oct;43(10):971-980. doi: 10.1007/s40264-020-00978-5. Drug Saf. 2020. PMID: 32734423 Free PMC article.
Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries.
Kolonics-Farkas AM, Šterclová M, Mogulkoc N, Lewandowska K, Müller V, Hájková M, Kramer M, Jovanovic D, Tekavec-Trkanjec J, Studnicka M, Stoeva N, Littnerová S, Vašáková M. Kolonics-Farkas AM, et al. Among authors: tekavec trkanjec j. Front Med (Lausanne). 2021 Dec 23;8:729203. doi: 10.3389/fmed.2021.729203. eCollection 2021. Front Med (Lausanne). 2021. PMID: 35004713 Free PMC article.
Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone.
Májek O, Gregor J, Mogulkoć N, Lewandowska K, Šterclová M, Müller V, Hájková M, Kramer MR, Tekavec-Trkanjec J, Jovanović D, Studnicka M, Stoeva N, Kirchgässler KU, Littnerová S, Dušek L, Vašáková MK. Májek O, et al. Among authors: tekavec trkanjec j. PLoS One. 2022 Sep 1;17(9):e0273854. doi: 10.1371/journal.pone.0273854. eCollection 2022. PLoS One. 2022. PMID: 36048805 Free PMC article.
A young man with transitory hemiparesis and lung infiltrates.
Ljilja A, Radović N, Tekavec-Trkanjec J. Ljilja A, et al. Among authors: tekavec trkanjec j. Breathe (Sheff). 2021 Dec;17(4):210069. doi: 10.1183/20734735.0069-2021. Breathe (Sheff). 2021. PMID: 35035563 Free PMC article.
26 results